摘要 |
The use of compounds of formula I, formula II, or formula III, for which the substituents are defined herein, in the manufacture of medicaments for the treatment of conditions associated with cell adhesion molecules, bronchial asthma, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, and other inflammatory and autoimmune disorders. (62) Divided out of 512851
|